| 1 |
Noh JH, Shin JY, Lee JH, Park YS, Lee IS, Kim GH, Na HK, Ahn JY, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY. Clinical Significance of Epstein-Barr Virus and Helicobacter pylori Infection in Gastric Carcinoma. Gut Liver 2023;17:69-77. [PMID: 35611669 DOI: 10.5009/gnl210593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Lee BE. Clinical Relevance of Helicobacter pylori Coinfection in Ebstein-Barr Virus-Associated Gastric Carcinoma. Gut Liver 2023;17:3-5. [PMID: 36636883 DOI: 10.5009/gnl220530] [Reference Citation Analysis]
|
| 3 |
Aviles-gaxiola S, Criollo-mendoza MS, García-carrasco M, Gutiérrez-grijalva EP, García-aguiar I, Heredia JB. Diseases with the highest mortality. Phytochemical Nanodelivery Systems as Potential Biopharmaceuticals 2023. [DOI: 10.1016/b978-0-323-90390-5.00001-3] [Reference Citation Analysis]
|
| 4 |
Patrad E, Khalighfard S, Amiriani T, Khori V, Alizadeh AM. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy. Cell Oncol (Dordr) 2022. [PMID: 36149600 DOI: 10.1007/s13402-022-00715-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Suzuki Y, Ito S, Nomura K, Matsui A, Kikuchi D, Hoteya S. Multiple Epstein-Barr virus-associated Gastric Cancers Arising in a Patient with Autoimmune Gastritis. Intern Med 2022. [PMID: 36171131 DOI: 10.2169/internalmedicine.0673-22] [Reference Citation Analysis]
|
| 6 |
Akkus S, Gareayaghi N, Saribas S, Demiryas S, Ozbey D, Kepil N, Demirci M, Ziver Sarp T, Oyku Dinc H, Akcin R, Uysal O, Tugberk Bakar M, Talha Aygun M, Bahar Tokman H, Kocazeybek B. Co-infection relationship with Epstein-Barr virus in gastroduodenal diseases with Helicobacter Pylori. Quantitative PCR and EBNA-1 gene-based approach. AGEB 2022;85:301-308. [DOI: 10.51821/85.2.9440] [Reference Citation Analysis]
|
| 7 |
Dzikowiec M, Lik P, Kiszałkiewicz J, Kuczyńska A, Mordalski M, Nejc D, Piekarski J, Brzeziańska-lasota E, Pastuszak-lewandoska D. Helicobacter pylori and Epstein-Barr Virus Co-Infection in Polish Patients with Gastric Cancer – A Pilot Study. Polish Journal of Microbiology 2022;0. [DOI: 10.33073/pjm-2022-004] [Reference Citation Analysis]
|
| 8 |
Sonkar C, Varshney N, Koganti S, Jha HC. Kinases and therapeutics in pathogen mediated gastric cancer. Mol Biol Rep 2022. [PMID: 35031925 DOI: 10.1007/s11033-021-07063-9] [Reference Citation Analysis]
|
| 9 |
Zhao K, Zhang Y, Xia S, Feng L, Zhou W, Zhang M, Dong R, Tian D, Liu M, Liao J. Epstein-Barr Virus is Associated with Gastric Cancer Precursor: Atrophic Gastritis. Int J Med Sci 2022;19:924-31. [PMID: 35693736 DOI: 10.7150/ijms.71820] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Retnakumar R, Nath AN, Nair GB, Chattopadhyay S. Gastrointestinal microbiome in the context of Helicobacter pylori infection in stomach and gastroduodenal diseases. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.07.001] [Reference Citation Analysis]
|
| 11 |
Abdi E, Latifi-Navid S, Abedi Sarvestani F, Esmailnejad MH. Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective. Expert Opin Ther Targets 2021;25:685-99. [PMID: 34410200 DOI: 10.1080/14728222.2021.1971195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Rihane FE, Erguibi D, Elyamine O, Abumsimir B, Ennaji MM, Chehab F. Helicobacter pylori co-infection with Epstein-Barr virus and the risk of developing gastric adenocarcinoma at an early age: Observational study infectious agents and cancer. Ann Med Surg (Lond) 2021;68:102651. [PMID: 34386233 DOI: 10.1016/j.amsu.2021.102651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Wong MCS, Huang J, Chan PSF, Choi P, Lao XQ, Chan SM, Teoh A, Liang P. Global Incidence and Mortality of Gastric Cancer, 1980-2018. JAMA Netw Open 2021;4:e2118457. [PMID: 34309666 DOI: 10.1001/jamanetworkopen.2021.18457] [Cited by in Crossref: 74] [Cited by in F6Publishing: 22] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 14 |
Stojanovic MM, Rancic NK, Andjelkovic Apostolovic MR, Ignjatovic AM, Ilic MV. Trends of Stomach Cancer in Central Serbia. Medicina (Kaunas) 2021;57:665. [PMID: 34203145 DOI: 10.3390/medicina57070665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Yazawa T, Sasaki B, Tani M, Sato A, Katsura H, Kamada Y, Tani R, Aoyama R, Sasaki Y, Shintaku M, Iwasa Y, Zaima M. Multiple Gastric Carcinomas Associated with Epstein-Barr Virus and Helicobacter pylori: A Thought-Provoking Case. Am J Case Rep 2021;22:e931668. [PMID: 34158469 DOI: 10.12659/AJCR.931668] [Reference Citation Analysis]
|
| 16 |
Yu P, Wang Y, Yu Y, Wang A, Huang L, Zhang Y, Liu W, Wu H, Yao M, Du YA, Cheng X. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma. Oncologist 2021;26:e756-68. [PMID: 33511732 DOI: 10.1002/onco.13695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Li W, Okabe A, Kaneda A. Epigenetic aberrations by Epstein–Barr virus infection to develop gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00006-x] [Reference Citation Analysis]
|
| 18 |
Dawson R, Jenkins BJ. Unravelling the pro-tumorigenic role of innate immune pattern recognition receptors in the gastric compartment. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00007-1] [Reference Citation Analysis]
|
| 19 |
Morales-Sánchez A, Torres J, Cardenas-Mondragón MG, Romo-González C, Camorlinga-Ponce M, Flores-Luna L, Fuentes-Pananá EM. Detection of Epstein-Barr Virus DNA in Gastric Biopsies of Pediatric Patients with Dyspepsia. Pathogens 2020;9:E623. [PMID: 32751557 DOI: 10.3390/pathogens9080623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Mikhaleva LM, Akopyan EP, Midiber KY, Vasyukova OA. Mixed-type gastric carcinoma: classification, morphological diagnosis and prognosis of the disease. jour 2020;98:197-202. [DOI: 10.30629/0023-2149-2020-98-3-197-202] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 21 |
Kartika AV, Iizasa H, Ding D, Kanehiro Y, Tajima Y, Kaji S, Yanai H, Yoshiyama H. Application of Biopsy Samples Used for Helicobacter pylori Urease Test to Predict Epstein-Barr Virus-Associated Cancer. Microorganisms 2020;8:E923. [PMID: 32570907 DOI: 10.3390/microorganisms8060923] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 22 |
Castaneda CA, Castillo M, Chavez I, Barreda F, Suarez N, Nieves J, Bernabe LA, Valdivia D, Ruiz E, Dias-Neto E, Landa-Baella MP, Bazan Y, Rengifo CA, Montenegro P. Prevalence of Helicobacter pylori Infection, Its Virulent Genotypes, and Epstein-Barr Virus in Peruvian Patients With Chronic Gastritis and Gastric Cancer. J Glob Oncol 2019;5:1-9. [PMID: 31479342 DOI: 10.1200/JGO.19.00122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Gouda G, Gupta MK, Donde R, Behera L, Vadde R. Monoclonal Antibody Therapy Against Gastrointestinal Tract Cancers. Immunotherapy for Gastrointestinal Malignancies 2020. [DOI: 10.1007/978-981-15-6487-1_7] [Reference Citation Analysis]
|
| 24 |
DE Flora S, LA Maestra S, Crocetti E, Mangone L, Bianconi F, Stracci F, Buzzoni C. Estimates of the incidence of infection-related cancers in Italy and Italian regions in 2018. J Prev Med Hyg 2019;60:E311-26. [PMID: 31967088 DOI: 10.15167/2421-4248/jpmh2019.60.4.1434] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 25 |
Ding S, Zhang Y. MicroRNA‑539 inhibits the proliferation and migration of gastric cancer cells by targeting SRY‑box 5 gene. Mol Med Rep 2019;20:2533-40. [PMID: 31322222 DOI: 10.3892/mmr.2019.10486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 26 |
Dominguez RL, Cherry CB, Estevez-Ordonez D, Mera R, Escamilla V, Pawlita M, Waterboer T, Wilson KT, Peek RM, Tavera G, Williams SM, Gulley ML, Emch M, Morgan DR. Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America. BMC Cancer 2019;19:545. [PMID: 31174492 DOI: 10.1186/s12885-019-5726-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 27 |
Maccormick TM, Carvalho CES, Bravo Neto GP, Carvalho MDGDC. Comparative analysis of glutathione transferase genetic polymorphism, Helicobacter pylori and Epstein-Barr virus between the tumor area and the proximal and distal resection margins of gastric cancer. Rev Col Bras Cir 2019;46:e2068. [PMID: 30726307 DOI: 10.1590/0100-6991e-20192068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 28 |
Del Moral-Hernández O, Castañón-Sánchez CA, Reyes-Navarrete S, Martínez-Carrillo DN, Betancourt-Linares R, Jiménez-Wences H, de la Peña S, Román-Román A, Hernández-Sotelo D, Fernández-Tilapa G. Multiple infections by EBV, HCMV and Helicobacter pylori are highly frequent in patients with chronic gastritis and gastric cancer from Southwest Mexico: An observational study. Medicine (Baltimore) 2019;98:e14124. [PMID: 30653141 DOI: 10.1097/MD.0000000000014124] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 29 |
Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14:26-38. [PMID: 30944675 DOI: 10.5114/pg.2018.80001] [Cited by in Crossref: 297] [Cited by in F6Publishing: 445] [Article Influence: 59.4] [Reference Citation Analysis]
|
| 30 |
Wang Z, Lv Z, Ding H, Xu Q, Sun L, Jing J, Yuan Y. Role of serum EBV-VCA IgG detection in assessing gastric cancer risk and prognosis in Northern Chinese population. Cancer Med 2018;7:5760-74. [PMID: 30306734 DOI: 10.1002/cam4.1792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 31 |
Fattahi S, Kosari‐monfared M, Ghadami E, Golpour M, Khodadadi P, Ghasemiyan M, Akhavan‐niaki H. Infection‐associated epigenetic alterations in gastric cancer: New insight in cancer therapy. J Cell Physiol 2018;233:9261-70. [DOI: 10.1002/jcp.27030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 32 |
Naseem M, Barzi A, Brezden-Masley C, Puccini A, Berger MD, Tokunaga R, Battaglin F, Soni S, McSkane M, Zhang W, Lenz HJ. Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 2018;66:15-22. [PMID: 29631196 DOI: 10.1016/j.ctrv.2018.03.006] [Cited by in Crossref: 81] [Cited by in F6Publishing: 88] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 33 |
Buzás GM. Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018. Minerva Gastroenterol Dietol 2018;64:280-96. [PMID: 29458240 DOI: 10.23736/S1121-421X.18.02481-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 34 |
Bakulin IG, Pirogov SS, Bakulina NV, Stadnik EA, Golubev NN. Prophylaxis and early diagnosis of stomach cancer. Dok gastroenterol 2018;7:44. [DOI: 10.17116/dokgastro201872244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 35 |
Pennington MR, Cossic BGA, Perkins GA, Duffy C, Duhamel GE, Van de Walle GR. First demonstration of equid gammaherpesviruses within the gastric mucosal epithelium of horses. Virus Res 2017;242:30-6. [PMID: 28870469 DOI: 10.1016/j.virusres.2017.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 36 |
Li JZ, Li JY, Wu TF, Xu JH, Huang CZ, Cheng D, Chen QK, Yu T. Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis. Gastroenterol Res Pract. 2017;2017:5715403. [PMID: 28883831 DOI: 10.1155/2017/5715403] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
|
